Data from new survey shows wide variation in access to primary PCI

Data from a new survey on primary percutaneous coronary intervention (pPCI) rates in 33 European Society of Cardiology (ESC) countries will be presented at the ESC Congress 2012 in Munich, Germany.

The data shows wide variation in access to pPCI and will be presented during a Stent for Life symposium.

Save the date:

Session: Stent for Life: Optimising Primary Percutaneous Coronary Intervention in Europe
When: Sunday 26 August 8:30am
Where: Dublin Room (Village 6)
ICM Messe-München
Messegelände, 81823,
Munich, Germany

Stent for Life is an initiative of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the registered branch of the ESC and EuroPCR aimed at ensuring that the majority of ST-elevated myocardial infarction (STEMI) patients have equal access to the life saving indication of pPCI.

During the session Professor Steen Dalby Kristensen will reveal preliminary, unpublished data from an EAPCI/ESC survey of 33 ESC countries which shows stark variations in pPCI rates across Europe.

Professor Petr Widimsky (Czech Republic), the first Stent for Life chair, will also present data showing that primary PCI is not just saving lives but is also cost effective.
Other presenters will discuss implementation challenges and successes in the Stent for Life countries.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mount Sinai researchers uncover genetic basis of fibromuscular dysplasia